256 related articles for article (PubMed ID: 4153721)
1. The effects of a new adrenergic blocking agent (K4423) on exercise tolerance in angina pectoris.
Libretti A; Gregorini L; Valentini R
Cardiology; 1973; 58(6):369-75. PubMed ID: 4153721
[No Abstract] [Full Text] [Related]
2. Effects of SD/1601 on tolerance to exercise in patients with angina.
Maggi A; Mariani G; Tettamanti R; Tallone G
G Ital Cardiol; 1975; 5(1):142-8. PubMed ID: 235477
[No Abstract] [Full Text] [Related]
3. [Penbutolol--a sinistrorotatory adrenergic beta-receptor blocking agent. Ergometer investigations in patients with angina pectoris].
Prahl P; Prahl M
Ugeskr Laeger; 1973 May; 135(20):965-8. PubMed ID: 4148295
[No Abstract] [Full Text] [Related]
4. Effect of a new beta-adrenergic blocking agent, ICI 66o82, on exercise haemodynamics and airway resistance in angina pectoris.
Aström H; Vallin H
Br Heart J; 1974 Dec; 36(12):1194-1200. PubMed ID: 4155316
[No Abstract] [Full Text] [Related]
5. Comparative effect of nadolol and propranolol on exercise tolerance in patients with angina pectoris.
Turner GG; Nelson RR; Nordstrom LA; Diefenthal HC; Gobel FL
Br Heart J; 1978 Dec; 40(12):1361-70. PubMed ID: 32899
[No Abstract] [Full Text] [Related]
6. Clinical trial of a new beta-receptor blocking agent, tolamolol, in angina pectoris.
Nordenfelt I; Olsson L; Persson S
Eur J Clin Pharmacol; 1974; 7(3):157-62. PubMed ID: 4152812
[No Abstract] [Full Text] [Related]
7. Effects of single doses of alprenolol and two cardioselective beta-blockers (H 87-07 and H 93-26) on exercise-induced angina pectoris.
Adolfsson L; Areskog NH; Furberg C; Johnsson G
Eur J Clin Pharmacol; 1974; 7(2):111-8. PubMed ID: 4152864
[No Abstract] [Full Text] [Related]
8. Effects of a new cardioselective beta-adrenergic blocker (tolamolol) on exercise tolerance in patients with angina pectoris.
Sood NK; Havard CW
Thorax; 1973 May; 28(3):331-4. PubMed ID: 4146782
[TBL] [Abstract][Full Text] [Related]
9. Effects of nipradilol, a new beta-blocking agent with vasodilating properties, on exercise tolerance in patients with stable effort angina: a double-blind study.
Araki H; Hayata N; Nakamura M
Clin Ther; 1987; 9(6):656-62. PubMed ID: 2894246
[TBL] [Abstract][Full Text] [Related]
10. Alprenolol in angina pectoris. A clinical and ergometric study with a new beta-adrenergic blocking agent.
Arstila M; Iisalo E; Kallio V
Ann Clin Res; 1969 May; 1(1):13-21. PubMed ID: 4390794
[No Abstract] [Full Text] [Related]
11. Cardio-selective beta-adrenergic inhibition by practolol in angina pectoris.
Frick MH; Katila M
Fortn Rev Chic Dent Soc; 1970 Sep; 60(5):96-101. PubMed ID: 4393719
[No Abstract] [Full Text] [Related]
12. Beta-adrenergic receptor blocking drugs in angina pectoris.
Prichard BN
Drugs; 1974; 7(1):55-84. PubMed ID: 4151695
[No Abstract] [Full Text] [Related]
13. Acute effects of oral alprenolol on exercise tolerance in patients with angina pectoris. A dose-response study.
Sealey BJ; Liljedal J; Nyberg G; Ablad B
Br Heart J; 1971 Jul; 33(4):481-8. PubMed ID: 4397626
[No Abstract] [Full Text] [Related]
14. Effect of practolol on exercise tolerance in patients with angina pectoris.
Sowton E; Smithen C; Leaver D; Barr I
Am J Med; 1971 Jul; 51(1):63-70. PubMed ID: 4398290
[No Abstract] [Full Text] [Related]
15. Effects of the cardioselective beta-adrenergic receptor blocking agent metoprolol in angina pectoris. Subacute study with exercise tests.
Ekelund LG; Olsson AG; Orö L; Rössner S
Br Heart J; 1976 Feb; 38(2):155-61. PubMed ID: 4080
[TBL] [Abstract][Full Text] [Related]
16. Effectiveness of sectral (M & B 17803A) as a beta-blocking agent in man.
Lewis BS; Bakst A; Kitchiner D; Gotsman MS
S Afr Med J; 1973 Jul; 47(27):1181-4. PubMed ID: 4146564
[No Abstract] [Full Text] [Related]
17. Effect of tolamolol versus propranolol on cardiovascular haemodynamics in patients with angina.
Aronow WS; March H; Vangrow JS; Cassidy J; Kern JC; Khemka M; Vawter M; Pagano J
Br Heart J; 1974 Nov; 36(11):1078-81. PubMed ID: 4155953
[No Abstract] [Full Text] [Related]
18. Comparison of once and twice daily oral dosing schedules of bevantolol, a new beta-adrenoceptor antagonist with alpha-adrenoceptor partial antagonist activity in patients with angina of effort.
Molajo AO; Bray CL; Hillier V
Int J Cardiol; 1989 Nov; 25(2):185-92. PubMed ID: 2572566
[TBL] [Abstract][Full Text] [Related]
19. Practolol in patients with angina pectoris.
Alderman EL; Davis RO; Friedman JP; Graham AF; Matlof HJ; Harrison DC
Clin Pharmacol Ther; 1973; 14(2):175-81. PubMed ID: 4144425
[No Abstract] [Full Text] [Related]
20. Dose finding in angina--results with epanolol.
Omland TM; von Brandis C; Abrahamsen AM
Drugs; 1989; 38 Suppl 2():35-8. PubMed ID: 2575978
[No Abstract] [Full Text] [Related]
[Next] [New Search]
